Phreesia’s (PHR) “Sector Perform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reissued their sector perform rating on shares of Phreesia (NYSE:PHR) in a research report sent to investors on Friday, Benzinga reports. They currently have a $23.00 price target on the stock.

Several other research analysts have also recently weighed in on PHR. Canaccord Genuity Group reissued a buy rating and issued a $34.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. JMP Securities reaffirmed a market outperform rating and set a $30.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Stephens reaffirmed an overweight rating and set a $28.00 price target on shares of Phreesia in a research report on Friday, May 31st. JPMorgan Chase & Co. upped their price target on Phreesia from $27.00 to $28.00 and gave the company an overweight rating in a research report on Monday, September 9th. Finally, Robert W. Baird upped their price target on Phreesia from $31.00 to $34.00 and gave the company an outperform rating in a research report on Friday, September 6th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of Moderate Buy and an average price target of $29.42.

Phreesia Stock Up 2.3 %

PHR stock opened at $22.72 on Friday. The stock’s fifty day simple moving average is $24.02 and its two-hundred day simple moving average is $22.63. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03. Phreesia has a 1-year low of $12.05 and a 1-year high of $29.16. The stock has a market cap of $1.31 billion, a P/E ratio of -10.47 and a beta of 0.93.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The business had revenue of $102.12 million for the quarter, compared to analysts’ expectations of $101.76 million. Analysts expect that Phreesia will post -1.23 EPS for the current year.

Insiders Place Their Bets

In other Phreesia news, CFO Balaji Gandhi sold 3,502 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $81,421.50. Following the transaction, the chief financial officer now directly owns 98,578 shares in the company, valued at approximately $2,291,938.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Balaji Gandhi sold 3,502 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total value of $81,421.50. Following the completion of the transaction, the chief financial officer now directly owns 98,578 shares in the company, valued at approximately $2,291,938.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP David Linetsky sold 1,820 shares of the stock in a transaction dated Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total value of $43,206.80. Following the sale, the senior vice president now owns 202,218 shares of the company’s stock, valued at $4,800,655.32. The disclosure for this sale can be found here. Insiders have sold 46,203 shares of company stock worth $1,129,699 in the last ninety days. 5.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Phreesia by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after buying an additional 194,035 shares in the last quarter. Capital International Investors increased its holdings in shares of Phreesia by 221.1% in the 1st quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock worth $62,052,000 after purchasing an additional 1,785,463 shares in the last quarter. Champlain Investment Partners LLC bought a new stake in shares of Phreesia in the 1st quarter worth $29,941,000. Ophir Asset Management Pty Ltd increased its holdings in shares of Phreesia by 24.1% in the 4th quarter. Ophir Asset Management Pty Ltd now owns 1,099,505 shares of the company’s stock worth $25,454,000 after purchasing an additional 213,805 shares in the last quarter. Finally, Blair William & Co. IL increased its holdings in shares of Phreesia by 42.6% in the 1st quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after purchasing an additional 224,950 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.